Sponsor Pipeline

Enveda Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
2
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT07643766
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults…		 Recruitment opened
2026-08-07 NCT07643766
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults…		 Trial sites expanded: 1 -> 9 locations
2026-07-30 NCT07301255
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults		 Trial sites expanded: 14 -> 18 locations
2026-07-30 NCT07298395
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis		 Trial sites expanded: 23 -> 32 locations
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07298395 Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis Atopic Dermatitis (AD) Recruiting
NCT07301255 ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults Asthma Recruiting
NCT07643766 A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults… Atopic Dermatitis Recruiting
Disease Areas
Atopic Dermatitis (2) Asthma (1)
Get alerts when Enveda Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free